サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1413502

シングルセルマルチオミックス市場：タイプ、技術、用途、エンドユーザー別-2024-2030年の世界予測

Single-Cell Multi-Omics Market by Type (Single Cell Genomics, Single Cell Metabolomics, Single Cell Proteomics), Technique (Single-Cell Analysis, Single-Cell Isolation & Dispensing), Application, End User - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
シングルセルマルチオミックス市場：タイプ、技術、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年01月16日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

シングルセルマルチオミックス市場規模は2023年に29億2,000万米ドルと推計され、2024年には31億8,000万米ドルに達し、CAGR 10.65%で2030年には59億3,000万米ドルに達すると予測されます。

シングルセルマルチオミックスの世界市場

主な市場の統計
基準年[2023］ 29億2,000万米ドル
予測年[2024］ 31億8,000万米ドル
予測年 [2030] 59億3,000万米ドル
CAGR（%） 10.65%
シングルセルマルチオミックス Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスはシングルセルマルチオミックス市場を評価する上で極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、シングルセルマルチオミックス市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1-市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2-市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3-市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4-競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5-製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1-シングルセルマルチオミックス市場の市場規模および予測は？

2-シングルセルマルチオミックス市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3-シングルセルマルチオミックス市場における技術動向と規制の枠組みは？

4-シングルセルマルチオミックス市場における主要ベンダーの市場シェアは？

5-シングルセルマルチオミックス市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界的にがんの症例と慢性疾患の数が増加
      • 単一細胞オミックスのための計算ツールとバイオインフォマティクス戦略の利用
      • 創薬と開発を加速するためにシングルセルマルチオミックスの採用が必要
    • 抑制要因
      • マルチオミクスプロジェクトの高コストと熟練人材の不足
    • 機会
      • シングルセルマルチオミックステクノロジーにおけるAIとMLの採用
      • エピゲノム、エピトランスクリプトーム、その他の新しいオミックスの出現
    • 課題
      • 大規模なデータセットの分析が困難であり、患者データのプライバシーに関連する懸念がある
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 シングルセルマルチオミックス市場：タイプ別

  • 単一細胞ゲノミクス
  • 単一細胞メタボロミクス
  • 単一細胞プロテオミクス
  • 単一細胞トランスクリプトミクス

第7章 シングルセルマルチオミックス市場：技術別

  • 単一細胞解析
  • 単一細胞の分離と分注

第8章 シングルセルマルチオミックス市場：用途別

  • 細胞生物学
  • 免疫学
  • 神経内科
  • 腫瘍学
  • 幹細胞調査

第9章 シングルセルマルチオミックス市場：エンドユーザー別

  • 学術機関
  • 受託調査機関
  • 製薬会社およびバイオテクノロジー企業

第10章 南北アメリカのシングルセルマルチオミックス市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第11章 アジア太平洋地域のシングルセルマルチオミックス市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第12章 欧州・中東・アフリカのシングルセルマルチオミックス市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第13章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ主要企業別の分析

第14章 競争力のあるポートフォリオ

  • 主要な企業プロファイル
    • 10x Genomics
    • Agilent Technologies, Inc.
    • Akoya Biosciences
    • Becton, Dickinson and Company
    • Berkeley Lights Inc.
    • BGI Genomics Co., Ltd.
    • Bio-Rad Laboratories, Inc.
    • Bruker Corporation
    • Cytena by Bico Group
    • Danaher Corporation
    • Dolomite Bio
    • Epicypher Inc.
    • Illumina, Inc
    • Merck KGaA
    • Miltenyi Biotec B.V. & CO.
    • Mission Bio, Inc.
    • Nanostring Technologies, Inc.
    • Olink Holding AB
    • Parse Bioscience
    • Qiagen NV
    • Standard BioTools Inc.
    • Takara Holdings Inc.
    • Thermo Fisher Scientific Inc.
    • Vizgen Inc.
  • 主要な製品ポートフォリオ

第15章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. SINGLE-CELL MULTI-OMICS MARKET RESEARCH PROCESS
  • FIGURE 2. SINGLE-CELL MULTI-OMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. SINGLE-CELL MULTI-OMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. SINGLE-CELL MULTI-OMICS MARKET DYNAMICS
  • FIGURE 7. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 10. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. SINGLE-CELL MULTI-OMICS MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. SINGLE-CELL MULTI-OMICS MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. SINGLE-CELL MULTI-OMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. SINGLE-CELL MULTI-OMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL GENOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL METABOLOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL PROTEOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE CELL TRANSCRIPTOMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 11. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE-CELL ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY SINGLE-CELL ISOLATION & DISPENSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY CELL BIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. SINGLE-CELL MULTI-OMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECH COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM SINGLE-CELL MULTI-OMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. SINGLE-CELL MULTI-OMICS MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 192. SINGLE-CELL MULTI-OMICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 193. SINGLE-CELL MULTI-OMICS MARKET LICENSE & PRICING
目次
Product Code: MRR-7C31448F0BC1

[189 Pages Report] The Single-Cell Multi-Omics Market size was estimated at USD 2.92 billion in 2023 and expected to reach USD 3.18 billion in 2024, at a CAGR 10.65% to reach USD 5.93 billion by 2030.

Global Single-Cell Multi-Omics Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.18 billion
Forecast Year [2030] USD 5.93 billion
CAGR (%) 10.65%
Single-Cell Multi-Omics Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Single-Cell Multi-Omics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Single-Cell Multi-Omics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Single-Cell Multi-Omics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Agilent Technologies, Inc., Akoya Biosciences, Becton, Dickinson and Company, Berkeley Lights Inc., BGI Genomics Co., Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, Cytena by Bico Group, Danaher Corporation, Dolomite Bio, Epicypher Inc., Illumina, Inc, Merck KGaA, Miltenyi Biotec B.V. & CO., Mission Bio, Inc., Nanostring Technologies, Inc., Olink Holding AB, Parse Bioscience, Qiagen NV, Standard BioTools Inc., Takara Holdings Inc., Thermo Fisher Scientific Inc., and Vizgen Inc..

Market Segmentation & Coverage

This research report categorizes the Single-Cell Multi-Omics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Single Cell Genomics
    • Single Cell Metabolomics
    • Single Cell Proteomics
    • Single Cell Transcriptomics
  • Technique
    • Single-Cell Analysis
    • Single-Cell Isolation & Dispensing
  • Application
    • Cell Biology
    • Immunology
    • Neurology
    • Oncology
    • Stem Cell Research
  • End User
    • Academic Institutes
    • Contract Research Organizations
    • Pharmaceutical & Biotech Companies
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Single-Cell Multi-Omics Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Single-Cell Multi-Omics Market?

3. What are the technology trends and regulatory frameworks in the Single-Cell Multi-Omics Market?

4. What is the market share of the leading vendors in the Single-Cell Multi-Omics Market?

5. Which modes and strategic moves are suitable for entering the Single-Cell Multi-Omics Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Single-Cell Multi-Omics Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising number of cancer cases and chronic disorders globally
      • 5.1.1.2. Utilization of computational tools and bioinformatics strategies for single-cell omics
      • 5.1.1.3. Need for adoption of single-cell multi-omics to accelerate drug discovery and development
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of multi-omics projects and lack of skilled personnel
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of AI and ML in single-cell multi-omics technologies
      • 5.1.3.2. Emergence of epigenome, epitranscriptome, and other new omics
    • 5.1.4. Challenges
      • 5.1.4.1. Difficult of analyzing large datasets and concerns associated with privacy of patient data
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Single-Cell Multi-Omics Market, by Type

  • 6.1. Introduction
  • 6.2. Single Cell Genomics
  • 6.3. Single Cell Metabolomics
  • 6.4. Single Cell Proteomics
  • 6.5. Single Cell Transcriptomics

7. Single-Cell Multi-Omics Market, by Technique

  • 7.1. Introduction
  • 7.2. Single-Cell Analysis
  • 7.3. Single-Cell Isolation & Dispensing

8. Single-Cell Multi-Omics Market, by Application

  • 8.1. Introduction
  • 8.2. Cell Biology
  • 8.3. Immunology
  • 8.4. Neurology
  • 8.5. Oncology
  • 8.6. Stem Cell Research

9. Single-Cell Multi-Omics Market, by End User

  • 9.1. Introduction
  • 9.2. Academic Institutes
  • 9.3. Contract Research Organizations
  • 9.4. Pharmaceutical & Biotech Companies

10. Americas Single-Cell Multi-Omics Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Single-Cell Multi-Omics Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Single-Cell Multi-Omics Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. 10x Genomics
    • 14.1.2. Agilent Technologies, Inc.
    • 14.1.3. Akoya Biosciences
    • 14.1.4. Becton, Dickinson and Company
    • 14.1.5. Berkeley Lights Inc.
    • 14.1.6. BGI Genomics Co., Ltd.
    • 14.1.7. Bio-Rad Laboratories, Inc.
    • 14.1.8. Bruker Corporation
    • 14.1.9. Cytena by Bico Group
    • 14.1.10. Danaher Corporation
    • 14.1.11. Dolomite Bio
    • 14.1.12. Epicypher Inc.
    • 14.1.13. Illumina, Inc
    • 14.1.14. Merck KGaA
    • 14.1.15. Miltenyi Biotec B.V. & CO.
    • 14.1.16. Mission Bio, Inc.
    • 14.1.17. Nanostring Technologies, Inc.
    • 14.1.18. Olink Holding AB
    • 14.1.19. Parse Bioscience
    • 14.1.20. Qiagen NV
    • 14.1.21. Standard BioTools Inc.
    • 14.1.22. Takara Holdings Inc.
    • 14.1.23. Thermo Fisher Scientific Inc.
    • 14.1.24. Vizgen Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing